Allergen Profile, Mold

This blood test checks whether your immune system has developed a sensitivity to common molds by measuring specific antibodies called IgE. A positive result means your immune system recognizes certain molds and may be contributing to symptoms like sneezing, itchy eyes, or breathing difficulties, but your doctor will combine this result with your medical history to determine if mold is truly causing your symptoms.

When elevated: Elevated mold-specific IgE (Class 2 and above, ≥0.71 kU/L) indicates sensitization and, when correlated with symptoms and exposure, supports a diagnosis of mold-triggered allergic disease such as allergic rhinitis, allergic asthma, or allergic bronchopulmonary aspergillosis (ABPA). High-level sensitization to Alternaria or Aspergillus is associated with increased risk of severe asthma exacerbations, near-fatal asthma, and accelerated lung function decline. Positive results should prompt environmental assessment, avoidance strategies, and consideration of allergen immunotherapy or targeted biologics. When low: A low or undetectable mold sIgE result (Class 0, <0.10 kU/L) suggests that IgE-mediated mold sensitization is unlikely to be contributing to the patient's symptoms. However, non-IgE-mediated mechanisms such as hypersensitivity pneumonitis, toxic mold exposure, or irritant effects of mold volatile organic compounds are not excluded by a negative panel. If clinical suspicion remains high, additional testing such as serum precipitins, bronchoalveolar lavage, or pulmonary function testing may be warranted.

Mold sensitization can trigger allergic rhinitis, asthma, or exercise-induced bronchoconstriction—all of which impair aerobic performance, training tolerance, and recovery. Athletes in humid environments (indoor pools, gyms, or damp training facilities) face higher mold exposure risk; identifying sensitization enables targeted environmental controls and medical management to preserve training capacity and competitive performance.